Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07776509 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07776509 · ClinicalTrials.gov record · last posted 2026-08-20

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Study acronym: SELENE 3
StatusNot Yet Recruiting
PhasePhase 3
Started2026-08-21
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The study will evaluate how well AZD6234 works and how safe it is in adults with excess weight or obesity. Efficacy of AZD6234 will be compared to placebo in percent body weight change from baseline at 68 weeks of treatment.
Trial Details
NCT Number NCT07776509
Lead Sponsor AstraZeneca
Conditions Obesity or Overweight, Weight-Related Comorbidity, With/Without Diabetes Mellitus, Type 2
Enrollment 500 participants
Start Date 2026-08-21
Primary Completion 2028-08-09 (estimated)
Study Completion 2028-08-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-20